The increasing recognition of genetic predisposition as a significant risk factor in the occurrence of these cancers emphasizes the importance of BRCA1 and BRCA2 genes in hereditary breast and ovarian cancer. Recent advancements in molecular techniques, including next-generation sequencing, have revealed a multitude of new genes linked to the vulnerability to breast and/or ovarian cancer. The gene discussed is BRCA1; the disease is ovarian cancer.